These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8752159)

  • 61. Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review.
    Varela-Lema L; Taioli E; Ruano-Ravina A; Barros-Dios JM; Anantharaman D; Benhamou S; Boccia S; Bhisey RA; Cadoni G; Capoluongo E; Chen CJ; Foulkes W; Goloni-Bertollo EM; Hatagima A; Hayes RB; Katoh T; Koifman S; Lazarus P; Manni JJ; Mahimkar M; Morita S; Park J; Park KK; Pavarino Bertelli EC; de Souza Fonseca Ribeiro EM; Roy B; Spitz MR; Strange RC; Wei Q; Ragin CC
    Genet Med; 2008 Jun; 10(6):369-84. PubMed ID: 18496222
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influence of genetic factors on toluene diisocyanate-related symptoms: evidence from a cross-sectional study.
    Broberg K; Tinnerberg H; Axmon A; Warholm M; Rannug A; Littorin M
    Environ Health; 2008 Apr; 7():15. PubMed ID: 18447907
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Polymorphisms in genes related to activation or detoxification of carcinogens might interact with smoking to increase renal cancer risk: results from The Netherlands Cohort Study on diet and cancer.
    Smits KM; Schouten LJ; van Dijk BA; van Houwelingen K; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Oosterwijk E; van den Brandt PA
    World J Urol; 2008 Feb; 26(1):103-10. PubMed ID: 17982751
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north indian population.
    Sobti RC; Sharma S; Joshi A; Jindal SK; Janmeja A
    Mol Cell Biochem; 2004 Nov; 266(1-2):1-9. PubMed ID: 15646021
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CYP1A1, GSTs and mEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high- incidence area in north China.
    Wang LD; Zheng S; Liu B; Zhou JX; Li YJ; Li JX
    World J Gastroenterol; 2003 Jul; 9(7):1394-7. PubMed ID: 12854128
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Candidate gene case-control association studies: advantages and potential pitfalls.
    Daly AK; Day CP
    Br J Clin Pharmacol; 2001 Nov; 52(5):489-99. PubMed ID: 11736857
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma.
    Liu G; Ghadirian P; Vesprini D; Hamel N; Paradis AJ; Lal G; Gallinger S; Narod SA; Foulkes WD
    Br J Cancer; 2000 May; 82(10):1646-9. PubMed ID: 10817498
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan.
    Huang CS; Shen CY; Chang KJ; Hsu SM; Chern HD
    Br J Cancer; 1999 Aug; 80(11):1838-43. PubMed ID: 10468307
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Environmental Genome Project: functional analysis of polymorphisms.
    Guengerich FP
    Environ Health Perspect; 1998 Jul; 106(7):365-8. PubMed ID: 9637792
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Animal models of human response to dioxins.
    Grassman JA; Masten SA; Walker NJ; Lucier GW
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):761-75. PubMed ID: 9599728
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of purified human recombinant cytochrome P4501A1-Ile462 and -Val462: assessment of a role for the rare allele in carcinogenesis.
    Zhang ZY; Fasco MJ; Huang L; Guengerich FP; Kaminsky LS
    Cancer Res; 1996 Sep; 56(17):3926-33. PubMed ID: 8752159
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Construction of thr461 --> Asn461 and Ile462 --> Val462 mutation vector of P4501A1 gene].
    Wei Q; Liu YM; Wang H; Zhao XL; Ren TL; Xiao YM
    Wei Sheng Yan Jiu; 2006 Sep; 35(5):540-2. PubMed ID: 17086697
    [TBL] [Abstract][Full Text] [Related]  

  • 74. cDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purification.
    Buters JT; Shou M; Hardwick JP; Korzekwa KR; Gonzalez FJ
    Drug Metab Dispos; 1995 Jul; 23(7):696-701. PubMed ID: 7587956
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe.
    Kaminsky LS; de Morais SM; Faletto MB; Dunbar DA; Goldstein JA
    Mol Pharmacol; 1993 Feb; 43(2):234-9. PubMed ID: 8429826
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility.
    Persson I; Johansson I; Ingelman-Sundberg M
    Biochem Biophys Res Commun; 1997 Feb; 231(1):227-30. PubMed ID: 9070254
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.